NovelStem International (NSTM) News Today → A lot of people are making this costly mistake (From WealthPress) (Ad) Free NSTM Stock Alerts $0.07 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and Merchandisingfinance.yahoo.com - July 13 at 8:50 PMGlencore Internationalforbes.com - April 24 at 10:24 AMNovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-Kfinance.yahoo.com - March 31 at 3:22 PMNovelStem's Affiliate NewStem Announced New Collaboration to Validate Its Software Diagnostic Device for Two Oncology Indications and Two Therapiesfinance.yahoo.com - December 14 at 9:59 AMNovelStem International Corp. (NSTM)finance.yahoo.com - October 20 at 4:34 PMNovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding, Provides Financial Updatefinance.yahoo.com - October 13 at 3:56 PMNovelstem International Corpreuters.com - August 27 at 12:01 AMBreast cancer survivor says her sports bra saved her lifeyahoo.com - April 15 at 12:47 AM9 Things That Millennials Who Grew Up In Puerto Rico Will Rememberyahoo.com - April 14 at 12:08 AMLatinx People Are Sharing Are Sharing "Untraditional" Beauty Tips From Their Abuelas And Moms, And I'm Taking Notesyahoo.com - April 14 at 12:08 AMNovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, Ltdfinance.yahoo.com - April 11 at 4:14 PMCampaigns With Heart Honored As 2022 Halo Award Finalistsyahoo.com - February 17 at 8:39 PMMedi-Weightloss Celebrates Growth and Prepares for Expansion in 2022yahoo.com - February 17 at 10:23 AMNovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Assetfinance.yahoo.com - February 15 at 12:07 PMNovelStem International Corp (NSTM)nasdaq.com - January 23 at 12:50 AM Get NovelStem International News Delivered to You Automatically Sign up to receive the latest news and ratings for NSTM and its competitors with MarketBeat's FREE daily newsletter. Email Address the most reliable asset on earth is making a comeback (Ad)Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal. And you can see how it works for FREE when you Click Here NSTM Media Mentions By Week NSTM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NSTM News Sentiment▼0.000.60▲Average Medical News Sentiment NSTM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NSTM Articles This Week▼00▲NSTM Articles Average Week Get NovelStem International News Delivered to You Automatically Sign up to receive the latest news and ratings for NSTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BCEL News ABMT News PCSA News MDVL News APLIF News UAHC News ARAV News NUWE News ADIL News LMDX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NSTM) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovelStem International Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.